Valbiotis SA (FR:ALVAL) has released an update.
Valbiotis SA, a French scientific research lab, has released its monthly voting rights and share capital data, showing a total of 15,794,596 shares and 16,435,425 exercisable voting rights as of September 30, 2024. The company, known for developing dietary supplements aimed at preventing metabolic disorders leading to cardiovascular diseases, emphasizes its innovative approach utilizing both terrestrial and marine plants. Valbiotis prides itself on collaborations with top academic centers and has financial backing from the European Union, with its products set for licensing agreements internationally and direct marketing in France.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.